{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:33:42Z","timestamp":1793226822418,"version":"4.5.0"},"reference-count":124,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100017540","name":"National Heart Lung and Blood Institute Division of Intramural Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jtha.2026.09.038","type":"journal-article","created":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T23:46:08Z","timestamp":1791243968000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pathogenic mechanisms and novel experimental anti-inflammatory therapies in hemophilic arthropathy"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-3079-4536","authenticated-orcid":false,"given":"Padmavathi","family":"Kavadipula","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2099-0585","authenticated-orcid":false,"given":"L. Vijaya Mohan","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2026.09.038_bib1","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1111\/j.1538-7836.2010.03962.x","article-title":"Blood-induced joint disease: the pathophysiology of hemophilic arthropathy","volume":"8","author":"Valentino","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.09.038_bib2","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.phrs.2016.11.032","article-title":"Pathophysiology of hemophilic arthropathy and potential targets for therapy","volume":"115","author":"Pulles","year":"2017","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jtha.2026.09.038_bib3","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1111\/jth.15444","article-title":"Hemophilic arthropathy: current knowledge and future perspectives","volume":"19","author":"Gualtierotti","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.09.038_bib4","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12929-021-00760-4","article-title":"Advances in the management of haemophilia: emerging treatments and their mechanisms","volume":"28","author":"Okaygoun","year":"2021","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.jtha.2026.09.038_bib5","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.3324\/haematol.2022.282099","article-title":"Emicizumab: the hemophilia A game-changer","volume":"109","author":"Alcedo Andrade","year":"2024","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2026.09.038_bib6","doi-asserted-by":"crossref","first-page":"4303","DOI":"10.3390\/jcm10194303","article-title":"Real-world data on bleeding patterns of hemophilia A patients treated with emicizumab","volume":"10","author":"Levy-Mendelovich","year":"2021","journal-title":"J Clin Med"},{"issue":"suppl 3","key":"10.1016\/j.jtha.2026.09.038_bib7","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1365-2516.2006.01268.x","article-title":"Pathogenesis of haemophilic arthropathy","volume":"12","author":"Roosendaal","year":"2006","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2026.09.038_bib8","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3390\/jcm6070063","article-title":"Pathophysiology of hemophilic arthropathy","volume":"6","author":"Melchiorre","year":"2017","journal-title":"J Clin Med"},{"key":"10.1016\/j.jtha.2026.09.038_bib9","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3389\/fphar.2014.00115","article-title":"Heme on innate immunity and inflammation","volume":"5","author":"Dutra","year":"2014","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jtha.2026.09.038_bib10","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1182\/blood-2010-05-284653","article-title":"Neoangiogenesis contributes to the development of hemophilic synovitis","volume":"117","author":"Acharya","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.09.038_bib11","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3390\/jcm13010225","article-title":"Blood-induced arthropathy: a major disabling complication of haemophilia","volume":"13","author":"Leuci","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.jtha.2026.09.038_bib12","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/17474086.2024.2438237","article-title":"NSAIDS\/COXIBS for the treatment of musculoskeletal pain secondary to hemophilic arthropathy","volume":"18","author":"Rodriguez-Merchan","year":"2025","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.jtha.2026.09.038_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40122-021-00345-x","article-title":"Current and emerging approaches for pain management in hemophilic arthropathy","volume":"11","author":"Gualtierotti","year":"2022","journal-title":"Pain Ther"},{"key":"10.1016\/j.jtha.2026.09.038_bib14","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/hae.13857","article-title":"Haemophilic arthropathy: a narrative review on the use of intra-articular drugs for arthritis","volume":"25","author":"Buccheri","year":"2019","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2026.09.038_bib15","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1182\/blood.2024027143","article-title":"Factor VIIa-released extracellular vesicles attenuate joint bleed-induced hemophilic arthropathy","volume":"147","author":"Kavadipula","year":"2026","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.09.038_bib16","first-page":"549","article-title":"Corrigendum to \u201cTreatment of hemophilic arthropathy by immunomodulatory extracellular vesicle delivered by liposome hybrid nanoparticles\u201d [Bioact. Mater. 40 (2024) 47-63]","volume":"54","author":"Wang","year":"2025","journal-title":"Bioact Mater"},{"key":"10.1016\/j.jtha.2026.09.038_bib17","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jconrel.2024.11.034","article-title":"Macrophage membrane-encapsulated miRNA nanodelivery system for the treatment of hemophilic arthritis","volume":"377","author":"Qian","year":"2025","journal-title":"J Control Release"},{"key":"10.1016\/j.jtha.2026.09.038_bib18","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3389\/fphys.2020.00541","article-title":"Pathophysiological role of synovitis in hemophilic arthropathy development: a two-hit hypothesis","volume":"11","author":"Calcaterra","year":"2020","journal-title":"Front Physiol"},{"key":"10.1016\/j.jtha.2026.09.038_bib19","doi-asserted-by":"crossref","first-page":"20221","DOI":"10.1074\/jbc.M610737200","article-title":"Characterization of heme as activator of Toll-like receptor 4","volume":"282","author":"Figueiredo","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jtha.2026.09.038_bib20","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/4310816","article-title":"Induction of NLRP3 inflammasome activation by heme in human endothelial cells","volume":"2018","author":"Erdei","year":"2018","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.jtha.2026.09.038_bib21","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/hae.14905","article-title":"Iron overload causes macrophages to produce a pro-inflammatory phenotype in the synovium of hemophiliac arthritis via the acetyl-p53 pathway","volume":"30","author":"Pang","year":"2024","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2026.09.038_bib22","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.thromres.2013.10.039","article-title":"Hemarthrosis in hemophilic mice results in alterations in M1-M2 monocyte\/macrophage polarization","volume":"133","author":"Nieuwenhuizen","year":"2014","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2026.09.038_bib23","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1055\/s-0038-1676796","article-title":"Macrophage polarization is deregulated in haemophilia","volume":"119","author":"Knowles","year":"2019","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.09.038_bib24","doi-asserted-by":"crossref","first-page":"88","DOI":"10.4274\/tjh.2016.0031","article-title":"The role of angiogenesis in haemophilic arthropathy: where do we stand and where are we going?","volume":"33","author":"Agapidou","year":"2016","journal-title":"Turk J Haematol"},{"key":"10.1016\/j.jtha.2026.09.038_bib25","doi-asserted-by":"crossref","first-page":"5505","DOI":"10.1182\/bloodadvances.2022007028","article-title":"The potential role of protease systems in hemophilic arthropathy","volume":"6","author":"Hauw","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2026.09.038_bib26","doi-asserted-by":"crossref","DOI":"10.1177\/1076029619892683","article-title":"Diagnostic values of inflammatory and angiogenic factors for acute joint bleeding in patients with severe hemophilia A","volume":"26","author":"Xu","year":"2020","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.jtha.2026.09.038_bib27","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1186\/s12891-017-1815-7","article-title":"Hemoglobin stimulates the expression of ADAMTS-5 and ADAMTS-9 by synovial cells: a possible cause of articular cartilage damage after intra-articular hemorrhage","volume":"18","author":"Tajima","year":"2017","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.jtha.2026.09.038_bib28","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.joca.2023.06.007","article-title":"Red blood cell exposure increases chondrocyte susceptibility to oxidative stress following hemarthrosis","volume":"31","author":"Lee","year":"2023","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.jtha.2026.09.038_bib29","doi-asserted-by":"crossref","first-page":"559","DOI":"10.3390\/jcm13020559","article-title":"Cartilage destruction by hemophilic arthropathy can be prevented by inhibition of the ferroptosis pathway in human chondrocytes","volume":"13","author":"Wagener","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.jtha.2026.09.038_bib30","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1093\/rheumatology\/keg220","article-title":"Haemoglobin-derived iron-dependent hydroxyl radical formation in blood-induced joint damage: an in vitro study","volume":"42","author":"Hooiveld","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jtha.2026.09.038_bib31","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/j.1365-2516.2008.01689.x","article-title":"Experimental haemophilic arthropathy in a mouse model of a massive haemarthrosis: gross, radiological and histological changes","volume":"14","author":"Hakobyan","year":"2008","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2026.09.038_bib32","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.knee.2012.05.006","article-title":"Intra-articular injections of hyaluronic acid induce positive clinical effects in knees of patients affected by haemophilic arthropathy","volume":"20","author":"Carulli","year":"2013","journal-title":"Knee"},{"key":"10.1016\/j.jtha.2026.09.038_bib33","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/hae.13711","article-title":"An exploratory comparison of single intra-articular injection of platelet-rich plasma vs hyaluronic acid in treatment of haemophilic arthropathy of the knee","volume":"25","author":"Li","year":"2019","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2026.09.038_bib34","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/ajh.2830270107","article-title":"Intraarticular methylprednisolone therapy in hemophilic arthropathy","volume":"27","author":"Shupak","year":"1988","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtha.2026.09.038_bib35","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1111\/j.1538-7836.2012.04851.x","article-title":"Intra-articular injection of mesenchymal stem cells expressing coagulation factor ameliorates hemophilic arthropathy in factor VIII-deficient mice","volume":"10","author":"Kashiwakura","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.09.038_bib36","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/ajh.2830120205","article-title":"Nonsteroidal anti-inflammatory drugs in the treatment of hemophilic arthropathy","volume":"12","author":"Thomas","year":"1982","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtha.2026.09.038_bib37","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1182\/blood-2004-09-3501","article-title":"Evaluation of the efficacy and safety of etoricoxib in the treatment of hemophilic arthropathy","volume":"107","author":"Tsoukas","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.09.038_bib38","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1046\/j.1365-2516.2000.00413.x","article-title":"Intra-articular hyaluronic acid in the treatment of haemophilic arthropathy of the knee. Clinical, radiological and sonographical assessment","volume":"6","author":"Wallny","year":"2000","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2026.09.038_bib39","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.reth.2025.10.017","article-title":"The platelet-rich plasma research ecosystem: from mechanistic insights to precision treatment in knee osteoarthritis","volume":"30","author":"Andia","year":"2025","journal-title":"Regen Ther"},{"key":"10.1016\/j.jtha.2026.09.038_bib40","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/hae.13212","article-title":"Platelet rich plasma for chronic synovitis treatment in patients with haemophilia","volume":"23","author":"Caviglia","year":"2017","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2026.09.038_bib41","doi-asserted-by":"crossref","first-page":"9140","DOI":"10.3390\/ijms25179140","article-title":"Treatment of chronic haemophilic synovitis with PRP: clinical and in vitro studies","volume":"25","author":"Caviglia","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtha.2026.09.038_bib42","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1186\/s12951-025-03591-9","article-title":"Exosomes derived from platelet-rich plasma alleviate synovial inflammation by enhancing synovial lymphatic function","volume":"23","author":"Liao","year":"2025","journal-title":"J Nanobiotechnology"},{"key":"10.1016\/j.jtha.2026.09.038_bib43","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1097\/CORR.0000000000002264","article-title":"No benefit to platelet-rich plasma over placebo injections in terms of pain or function in patients with hemophilic knee arthritis: a randomized trial","volume":"480","author":"Duan","year":"2022","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.jtha.2026.09.038_bib44","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s00277-026-07055-4","article-title":"Efficacy and safety of platelet-rich plasma injection for hemophilic chronic synovitis and arthropathy: a systematic review and meta-analysis","volume":"105","author":"Yin","year":"2026","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jtha.2026.09.038_bib45","article-title":"The effect of intra-articular corticosteroids on articular cartilage: a systematic review","volume":"3","author":"Wernecke","year":"2015","journal-title":"Orthop J Sports Med"},{"key":"10.1016\/j.jtha.2026.09.038_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2022.100987","article-title":"The fear for adverse bleeding and cardiovascular events in hemophilia patients using (non-)selective non-steroidal anti-inflammatory drugs: a systematic review reporting on safety","volume":"56","author":"van Bergen","year":"2022","journal-title":"Blood Rev"},{"issue":"suppl 1","key":"10.1016\/j.jtha.2026.09.038_bib47","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.1111\/jth.12933","article-title":"Mesenchymal stem cell treatment for hemophilia: a review of current knowledge","volume":"13","author":"Sokal","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.09.038_bib48","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/jth.12101","article-title":"Nuclear factor (NF)-kappaB and its associated pathways are major molecular regulators of blood-induced joint damage in a murine model of hemophilia","volume":"11","author":"Sen","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.09.038_bib49","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1055\/a-2071-0477","article-title":"Activation of the acute-phase response in hemophilia","volume":"123","author":"Knowles","year":"2023","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.09.038_bib50","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1182\/blood-2015-03-635524","article-title":"IL-1\u03b2, in contrast to TNF\u03b1, is pivotal in blood-induced cartilage damage and is a potential target for therapy","volume":"126","author":"van Vulpen","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.09.038_bib51","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1182\/blood-2017-12-820571","article-title":"Blood-induced bone loss in murine hemophilic arthropathy is prevented by blocking the iRhom2\/ADAM17\/TNF-\u03b1 pathway","volume":"132","author":"Haxaire","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.09.038_bib52","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/jth.12176","article-title":"IL-6 receptor antagonist as adjunctive therapy with clotting factor replacement to protect against bleeding-induced arthropathy in hemophilia","volume":"11","author":"Narkbunnam","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.09.038_bib53","doi-asserted-by":"crossref","first-page":"939","DOI":"10.3390\/jcm8070939","article-title":"TNF-alpha\/TNF-R system may represent a crucial mediator of proliferative synovitis in hemophilia A","volume":"8","author":"Manetti","year":"2019","journal-title":"J Clin Med"},{"key":"10.1016\/j.jtha.2026.09.038_bib54","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3390\/jcm9010075","article-title":"A translational study of TNF-alpha antagonists as an adjunctive therapy for preventing hemophilic arthropathy","volume":"9","author":"Zhang","year":"2019","journal-title":"J Clin Med"},{"key":"10.1016\/j.jtha.2026.09.038_bib55","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1182\/blood.2019003824","article-title":"EPCR deficiency or function-blocking antibody protects against joint bleeding-induced pathology in hemophilia mice","volume":"135","author":"Magisetty","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.09.038_bib56","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/S0002-9440(10)63889-8","article-title":"Short-term exposure of cartilage to blood results in chondrocyte apoptosis","volume":"162","author":"Hooiveld","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jtha.2026.09.038_bib57","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1302\/0301-620X.80B3.0800540","article-title":"Iron deposits and catabolic properties of synovial tissue from patients with haemophilia","volume":"80","author":"Roosendaal","year":"1998","journal-title":"J Bone Joint Surg Br"},{"key":"10.1016\/j.jtha.2026.09.038_bib58","doi-asserted-by":"crossref","DOI":"10.1177\/19476035221098167","article-title":"The role of interleukin-4 and interleukin-10 in osteoarthritic joint disease: a systematic narrative review","volume":"13","author":"van Helvoort","year":"2022","journal-title":"Cartilage"},{"key":"10.1016\/j.jtha.2026.09.038_bib59","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.joca.2012.04.002","article-title":"IL-4 alone and in combination with IL-10 protects against blood-induced cartilage damage","volume":"20","author":"van Meegeren","year":"2012","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.jtha.2026.09.038_bib60","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1093\/rheumatology\/ket005","article-title":"A short time window to profit from protection of blood-induced cartilage damage by IL-4 plus IL-10","volume":"52","author":"van Meegeren","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jtha.2026.09.038_bib61","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/bjh.12148","article-title":"A single intra-articular injection with IL-4 plus IL-10 ameliorates blood-induced cartilage degeneration in haemophilic mice","volume":"160","author":"van Meegeren","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2026.09.038_bib62","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1111\/jth.13778","article-title":"A fusion protein of interleukin-4 and interleukin-10 protects against blood-induced cartilage damage in vitro and in vivo","volume":"15","author":"van Vulpen","year":"2017","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.09.038_bib63","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1182\/blood.2024027578","article-title":"The interleukin-33 receptor (ST2) is a novel therapeutic target to attenuate the progression of hemophilic arthropathy","volume":"146","author":"Hawerkamp","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.09.038_bib64","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1111\/j.1538-7836.2006.02166.x","article-title":"Potential role of recombinant factor FVIIa in prophylaxis in severe hemophilia patients with inhibitors","volume":"4","author":"Hedner","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.09.038_bib65","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1182\/blood-2010-09-310706","article-title":"Factor VIIa bound to endothelial cell protein C receptor activates protease activated receptor-1 and mediates cell signaling and barrier protection","volume":"117","author":"Sen","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.09.038_bib66","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/jth.12532","article-title":"Factor VIIa binding to endothelial cell protein C receptor protects vascular barrier integrity in vivo","volume":"12","author":"Sundaram","year":"2014","journal-title":"J Thromb Haemos"},{"key":"10.1016\/j.jtha.2026.09.038_bib67","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1182\/blood-2017-10-813527","article-title":"Factor VIIa induces anti-inflammatory signaling via EPCR and PAR1","volume":"131","author":"Kondreddy","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.09.038_bib68","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1161\/ATVBAHA.120.314244","article-title":"FVIIa (Factor VIIa) induces biased cytoprotective signaling in mice through the cleavage of PAR (protease-activated receptor)-1 at canonical Arg41 (arginine41) site","volume":"40","author":"Kondreddy","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jtha.2026.09.038_bib69","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1182\/blood-2003-05-1369","article-title":"Improved hemostasis with superactive analogs of factor VIIa in a mouse model of hemophilia A","volume":"102","author":"Tranholm","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.09.038_bib70","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1182\/blood.2021012358","article-title":"Factor VIIa suppresses inflammation and barrier disruption through the release of EEVs and transfer of microRNA 10a","volume":"139","author":"Das","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.09.038_bib71","doi-asserted-by":"crossref","DOI":"10.3402\/jev.v4.27066","article-title":"Biological properties of extracellular vesicles and their physiological functions","volume":"4","author":"Y\u00e1\u00f1ez-M\u00f3","year":"2015","journal-title":"J Extracell Vesicles"},{"key":"10.1016\/j.jtha.2026.09.038_bib72","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1083\/jcb.201211138","article-title":"Extracellular vesicles: exosomes, microvesicles, and friends","volume":"200","author":"Raposo","year":"2013","journal-title":"J Cell Biol"},{"key":"10.1016\/j.jtha.2026.09.038_bib73","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12404","article-title":"Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches","volume":"13","author":"Welsh","year":"2024","journal-title":"J Extracell Vesicles"},{"key":"10.1016\/j.jtha.2026.09.038_bib74","doi-asserted-by":"crossref","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jtha.2026.09.038_bib75","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/0002-9343(79)90392-9","article-title":"Isolated deficiency of platelet procoagulant activity","volume":"67","author":"Weiss","year":"1979","journal-title":"Am J Med"},{"key":"10.1016\/j.jtha.2026.09.038_bib76","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/09537109709169326","article-title":"Scott syndrome: an inherited defect of the procoagulant activity of platelets","volume":"8","author":"Satta","year":"1997","journal-title":"Platelets"},{"key":"10.1016\/j.jtha.2026.09.038_bib77","doi-asserted-by":"crossref","first-page":"12800","DOI":"10.1073\/pnas.1516594112","article-title":"TMEM16F is required for phosphatidylserine exposure and microparticle release in activated mouse platelets","volume":"112","author":"Fujii","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtha.2026.09.038_bib78","doi-asserted-by":"crossref","first-page":"14586","DOI":"10.1016\/S0021-9258(18)82371-7","article-title":"Platelet-derived microparticle formation involves glycoprotein IIb-IIIa. Inhibition by RGDS and a Glanzmann\u2019s thrombasthenia defect","volume":"268","author":"Gemmell","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jtha.2026.09.038_bib79","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1046\/j.1365-2141.1997.d01-2072.x","article-title":"Characterization of a novel bleeding disorder with isolated prolonged bleeding time and deficiency of platelet microvesicle generation","volume":"96","author":"Castaman","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2026.09.038_bib80","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1161\/CIRCRESAHA.110.233056","article-title":"Microparticles in hemostasis and thrombosis","volume":"108","author":"Owens","year":"2011","journal-title":"Circ Res"},{"issue":"suppl 2","key":"10.1016\/j.jtha.2026.09.038_bib81","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/j.thromres.2012.02.025","article-title":"Microparticles as a circulating source of procoagulant and fibrinolytic activities in the circulation","volume":"129","author":"Lacroix","year":"2012","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2026.09.038_bib82","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1055\/s-0039-1688570","article-title":"Tissue factor-negative cell-derived microparticles play a distinctive role in hemostasis: a viewpoint review","volume":"45","author":"Horstman","year":"2019","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2026.09.038_bib83","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.blre.2012.12.002","article-title":"Extracellular vesicles in physiological and pathological conditions","volume":"27","author":"Yuana","year":"2013","journal-title":"Blood Rev"},{"key":"10.1016\/j.jtha.2026.09.038_bib84","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1161\/ATVBAHA.120.314644","article-title":"Platelet extracellular vesicles: beyond the blood","volume":"41","author":"Puhm","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jtha.2026.09.038_bib85","doi-asserted-by":"crossref","first-page":"4932","DOI":"10.3390\/jcm11164932","article-title":"Pathophysiology of coagulation and emerging roles for extracellular vesicles in coagulation cascades and disorders","volume":"11","author":"Al-Koussa","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.jtha.2026.09.038_bib86","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1080\/08982104.2025.2495261","article-title":"Platelet-derived extracellular vesicles: emerging players in hemostasis and thrombosis","volume":"35","author":"Kubaev","year":"2025","journal-title":"J Liposome Res"},{"key":"10.1016\/j.jtha.2026.09.038_bib87","doi-asserted-by":"crossref","DOI":"10.1080\/20013078.2019.1688936","article-title":"Extracellular vesicles and coagulation in blood from healthy humans revisited","volume":"8","author":"Berckmans","year":"2019","journal-title":"J Extracell Vesicles"},{"key":"10.1016\/j.jtha.2026.09.038_bib88","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.1182\/blood.2020008417","article-title":"Factor VIIa induces extracellular vesicles from the endothelium; a potential mechanism for its hemostatic effect","volume":"137","author":"Das","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.09.038_bib89","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1016\/j.jtha.2024.07.022","article-title":"Coagulation protease-induced extracellular vesicles: their potential effects on coagulation and inflammation","volume":"22","author":"Das","year":"2024","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.09.038_bib90","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1365-2141.2005.05792.x","article-title":"Circulating microparticles are elevated in haemophiliacs and non-haemophilic individuals aged <18 years","volume":"131","author":"Proulle","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2026.09.038_bib91","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/bjh.14799","article-title":"Immune status of patients with haemophilia A before exposure to factor VIII: first results from the HEMFIL study","volume":"178","author":"Jardim","year":"2017","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2026.09.038_bib92","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1160\/TH03-05-0301","article-title":"Injection of recombinant activated factor VII can induce transient increase in circulating procoagulant microparticles","volume":"91","author":"Proulle","year":"2004","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.09.038_bib93","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1111\/jth.15768","article-title":"Factor VIIa treatment increases circulating extracellular vesicles in hemophilia patients: implications for the therapeutic hemostatic effect of FVIIa","volume":"20","author":"Das","year":"2022","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.09.038_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcmd.2020.102441","article-title":"Differential response to FEIBA is strongly associated with the prothrombotic microparticles","volume":"84","author":"Soni","year":"2020","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.jtha.2026.09.038_bib95","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/hae.12873","article-title":"Pro- and anticoagulant factors facilitate thrombin generation and balance the haemostatic response to FEIBA((R)) in prophylactic therapy","volume":"22","author":"Varadi","year":"2016","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2026.09.038_bib96","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/jth.15223","article-title":"Decreased platelet surface phosphatidylserine predicts increased bleeding in patients with severe factor VIII deficiency","volume":"19","author":"Croteau","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.09.038_bib97","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/jth.12103","article-title":"Is a decrease of microparticles related to improvement of hemostasis after FVIII injection in hemophilia A patients treated on demand?","volume":"11","author":"Mobarrez","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.09.038_bib98","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/nm899","article-title":"Interaction of P-selectin and PSGL-1 generates microparticles that correct hemostasis in a mouse model of hemophilia A","volume":"9","author":"Hrachovinov\u00e1","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.jtha.2026.09.038_bib99","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/imr.13106","article-title":"Circulating tissue factor-positive extracellular vesicles and their association with thrombosis in different diseases","volume":"312","author":"Hisada","year":"2022","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jtha.2026.09.038_bib100","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12240","article-title":"Proteomic analysis of MSC-derived apoptotic vesicles identifies Fas inheritance to ameliorate haemophilia A via activating platelet functions","volume":"11","author":"Zhang","year":"2022","journal-title":"J Extracell Vesicles"},{"key":"10.1016\/j.jtha.2026.09.038_bib101","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41413-020-0100-9","article-title":"Exosomes: roles and therapeutic potential in osteoarthritis","volume":"8","author":"Ni","year":"2020","journal-title":"Bone Res"},{"key":"10.1016\/j.jtha.2026.09.038_bib102","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.949690","article-title":"Exosomes in osteoarthritis: updated insights on pathogenesis, diagnosis, and treatment","volume":"10","author":"Fan","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.jtha.2026.09.038_bib103","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3390\/cimb47020127","article-title":"MiR-451 in inflammatory diseases: molecular mechanisms, biomarkers, and therapeutic applications-a comprehensive review beyond oncology","volume":"47","author":"Wang","year":"2025","journal-title":"Curr Issues Mol Biol"},{"key":"10.1016\/j.jtha.2026.09.038_bib104","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jtha.2023.10.021","article-title":"MicroRNA-10a enrichment in factor VIIa-released endothelial extracellular vesicles: potential mechanisms","volume":"22","author":"Das","year":"2024","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.09.038_bib105","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232415479","article-title":"The role of microRNAs in inflammation","volume":"23","author":"Das","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtha.2026.09.038_bib106","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1007\/s10753-019-01032-y","article-title":"Novel piperazino-enaminones decrease pro-inflammatory cytokines following hemarthrosis in a hemophilia mouse model","volume":"42","author":"Zhong","year":"2019","journal-title":"Inflammation"},{"key":"10.1016\/j.jtha.2026.09.038_bib107","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124291","article-title":"Anti-inflammatory effect of a novel piperazino-enaminone delivered by liposomes in a mouse model of hemophilic arthropathy","volume":"659","author":"Zhong","year":"2024","journal-title":"Int J Pharm"},{"key":"10.1016\/j.jtha.2026.09.038_bib108","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejim.2025.01.030","article-title":"Bridging the gap: time to integrate sex and gender differences into research and clinical practice for improved health outcomes","volume":"134","author":"Gualtierotti","year":"2025","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.jtha.2026.09.038_bib109","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nri.2016.90","article-title":"Sex differences in immune responses","volume":"16","author":"Klein","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jtha.2026.09.038_bib110","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13293-026-00840-w","article-title":"Sex differences in disease severity and immune responses in murine and human inflammatory arthritis","volume":"17","author":"Hemshekhar","year":"2026","journal-title":"Biol Sex Differ"},{"key":"10.1016\/j.jtha.2026.09.038_bib111","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1111\/jth.15397","article-title":"A new hemophilia carrier nomenclature to define hemophilia in women and girls: communication from the SSC of the ISTH","volume":"19","author":"van Galen","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.09.038_bib112","article-title":"Gender equity in hemophilia: need for healthcare, familial, and societal advocacy","volume":"11","author":"Gualtierotti","year":"2024","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jtha.2026.09.038_bib113","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nri3622","article-title":"Regulation of immune responses by extracellular vesicles","volume":"14","author":"Robbins","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jtha.2026.09.038_bib114","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s40824-022-00300-7","article-title":"The role of extracellular vesicles in osteoarthritis treatment via microenvironment regulation","volume":"26","author":"Yin","year":"2022","journal-title":"Biomater Res"},{"key":"10.1016\/j.jtha.2026.09.038_bib115","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13036-025-00594-w","article-title":"Extracellular vesicles for macrophage reprogramming: an emerging paradigm in immunomodulatory therapeutics","volume":"20","author":"Jo","year":"2025","journal-title":"J Biol Eng"},{"key":"10.1016\/j.jtha.2026.09.038_bib116","doi-asserted-by":"crossref","first-page":"H1181","DOI":"10.1152\/ajpheart.00579.2020","article-title":"Extracellular vesicles: new players in regulating vascular barrier function","volume":"319","author":"Chatterjee","year":"2020","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jtha.2026.09.038_bib117","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12305","article-title":"Current challenges and future directions for engineering extracellular vesicles for heart, lung, blood and sleep diseases","volume":"12","author":"Li","year":"2023","journal-title":"J Extracell Vesicles"},{"key":"10.1016\/j.jtha.2026.09.038_bib118","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.tibtech.2024.08.007","article-title":"Engineering therapeutical extracellular vesicles for clinical translation","volume":"43","author":"Ma","year":"2025","journal-title":"Trends Biotechnol"},{"key":"10.1016\/j.jtha.2026.09.038_bib119","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1161\/CIRCRESAHA.123.323054","article-title":"The discovery of extracellular vesicles and their emergence as a next-generation therapy","volume":"135","author":"Rai","year":"2024","journal-title":"Circ Res"},{"issue":"Suppl 6","key":"10.1016\/j.jtha.2026.09.038_bib120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/hae.14046","article-title":"WFH Guidelines for the Management of Hemophilia panelists and co-authors. WFH guidelines for the management of hemophilia, 3rd edition","volume":"26","author":"Srivastava","year":"2020","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2026.09.038_bib121","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12690","article-title":"The hemophilia joint health score version 2.1 validation in adult patients study: a multicenter international study","volume":"6","author":"St-Louis","year":"2022","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.09.038_bib122","doi-asserted-by":"crossref","first-page":"178","DOI":"10.2478\/raon-2019-0027","article-title":"Diagnostic accuracy of haemophilia early arthropathy detection with ultrasound (HEAD-US): a comparative magnetic resonance imaging (MRI) study","volume":"53","author":"Plut","year":"2019","journal-title":"Radiol Oncol"},{"key":"10.1016\/j.jtha.2026.09.038_bib123","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/MBC.0000000000000934","article-title":"HJHS 2.1 and HEAD-US assessment in the hemophilic joints: how do their findings compare?","volume":"31","author":"De la Corte-Rodriguez","year":"2020","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.jtha.2026.09.038_bib124","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0248952","article-title":"Correlation between hemophilia early arthropathy detection with ultrasound (HEAD-US) score and hemophilia joint health score (HJHS) in patients with hemophilic arthropathy","volume":"16","author":"Prasetyo","year":"2021","journal-title":"PLoS One"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783626006288?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783626006288?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:14:07Z","timestamp":1793225647000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783626006288"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":124,"alternative-id":["S1538783626006288"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2026.09.038","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathogenic mechanisms and novel experimental anti-inflammatory therapies in hemophilic arthropathy","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2026.09.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}